XML 71 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity (Details)
 12 Months Ended
Dec. 26, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Jul. 31, 2023
USD ($)
Equity [Abstract]        
Common stock, shares authorized (in shares) | shares   300,000,000 300,000,000  
Preferred stock, shares authorized (in shares) | shares   10,000,000    
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001  
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001    
Preferred stock, shares outstanding (in shares) | shares   0    
Proceeds from sale of common stock and pre-funded warrants, net of issuance cost | $ $ 4,651,163 $ 47,580,000    
Number of securities called by warrants or rights (in shares) | shares 3,100,823 3,100,823    
Proceeds from sale of common stock and pre-funded warrants, net of issuance cost | $ $ 47,600,000 $ 48,170,000 $ 0  
Sale of stock (in dollars per share) | $ / shares $ 6.45      
Price of pre-funded warrants (in dollars per share) | $ / shares 6.4499      
Exercise price of warrants or rights | $ / shares $ 0.0001      
Number of securities called by each warrant or right (share per share) | shares 1      
Pre-funded warrants, ownership limitation post-exercise 0.0999      
Sale of stock maximum aggregate sales price | $       $ 75,000,000
Sale of stock commission       3.00%